With Phase 1 testing now complete and showing positive results, U.S.
Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.
Read More
With Phase 1 testing now complete and showing positive results, U.S.
Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.
Read MoreWritten by
Specializing in pharmaceutical manufacturing, regulatory‑compliant digital marketing, and healthcare industry growth strategies. This multidisciplinary team provides subject‑matter expertise relevant to USSF’s cGMP operations, botanical injectables, and clinical education initiatives.